Visual hallucinations following treatment with vincristine

Clin Lab Haematol. 1994 Dec;16(4):355-7. doi: 10.1111/j.1365-2257.1994.tb00434.x.

Abstract

Peripheral neuropathy is a common side effect of vincristine therapy. However, side effects due to central nervous system (CNS) toxicity following intravenous administration are rare. We report two patients who developed visual hallucinations during treatment with vincristine.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Carmustine / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Hallucinations / chemically induced*
  • Humans
  • Lymphoma, T-Cell / complications
  • Lymphoma, T-Cell / drug therapy
  • Male
  • Melphalan / administration & dosage
  • Methotrexate / administration & dosage
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy
  • Prednisolone / administration & dosage
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Salvage Therapy
  • Serotonin / chemistry
  • Structure-Activity Relationship
  • Vincristine / administration & dosage
  • Vincristine / adverse effects*
  • Vincristine / chemistry

Substances

  • Bleomycin
  • Serotonin
  • Procarbazine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Melphalan
  • Carmustine
  • Prednisone
  • Methotrexate

Supplementary concepts

  • ABCM protocol
  • CHOP protocol
  • PACE-BOM protocol
  • VAMP protocol